In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
9 authors.
Ravi Shankar PalaniDepartment of Chemistry and Francis Bitter Magnet Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.ORCID 0000-0003-3528-7788 Christopher G WilliamsDepartment of Chemistry, University of California, Riverside, CA 92521, United States.ORCID 0009-0009-8319-4413 Robert SilversDepartment of Chemistry & Biochemistry and Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306, United States.ORCID 0000-0003-0197-3878 Leonard J MuellerDepartment of Chemistry, University of California, Riverside, CA 92521, United States.ORCID 0000-0002-2607-9875 Robert G GriffinDepartment of Chemistry and Francis Bitter Magnet Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.ORCID 0000-0003-1589-832X Funding
Solid State NMR Studies of Amyloid ProteinsR01AG058504 · NIA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ROBERT Guy GRIFFIN · 2022 to 2026
$3.5MSolid State NMR Studies of Amyloid ProteinsRF1AG058504 · NIA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GRIFFIN, ROBERT GUY · 2017 to 2017
$3.1MNMR crystallography: Imaging active site chemistry and protonation statesR35GM145369 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Leonard J Mueller · 2022 to 2026
$2.1M600 MHz NMR Spectrometer and CPMAS CryoProbeS10OD032197 · OD · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI MUELLER, LEONARD J · 2022 to 2022
$2.0MStructural Co-evolution of the LARP Superfamily and its Role in Functional PlasticityR35GM142912 · NIGMS · FLORIDA STATE UNIVERSITY · PI SILVERS, ROBERT · 2021 to 2025
$2.0MNIA NIH HHS R01 AG058504NIA NIH HHS RF1 AG058504NIGMS NIH HHS R35 GM142912NIGMS NIH HHS R35 GM145369NIH HHS S10 OD032197
6 · The paper itselfAbstract
Aducanumab, a human IgG1 antibody with plaque-clearing effects and modest clinical benefit, binds selectively to aggregated Aβ via the N-terminal region. Yet, the molecular details of how the antibody engages Aβ
Indexed as
aducanumabAmyloid-βantibodyBiological Sciences/Biophysics and Computational Biologymagic angle spinningnuclear magnetic resonancePhysical Sciences/Biophysics and Computational Biology
Identifiers
PMID41279514
PMCPMC12637657
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390